Susquehanna International Group’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-53,276	Closed	-$1.23M	–	6110
2020 Q4	$1.23M	Buy	+53,276	New	+$1.23M	﹤0.01%	2317